At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SIGA SIGA Technologies Inc.
Trading 12-11 15:31:36 EST
6.51
+0.26
+4.16%
High6.55Low6.25Vol300.00K
Open6.30D1 Closing6.25Amplitude4.72%
Mkt Cap466.19MTradable Cap264.17MTotal Shares71.61M
T/O1.93MT/O Rate0.74%Tradable Shares40.58M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

SIGA Technologies’ Earnings Call Highlights Growth and Challenges
TIPRANKS  ·  11-08
SIGA Technologies’ Earnings Call Highlights Growth and Challenges
SIGA Technologies Down Over 18%, on Pace for Largest Percent Decrease Since August 2024 -- Data Talk
Dow Jones  ·  11-08
SIGA Technologies Down Over 18%, on Pace for Largest Percent Decrease Since August 2024 -- Data Talk
SIGA Technologies Reports Q3 2025 Financial Results
TIPRANKS  ·  11-07
SIGA Technologies Reports Q3 2025 Financial Results
SIGA Technologies Highlights TPOXX Expansion and Global Health Strategy in New Management Presentation
Reuters  ·  11-07
SIGA Technologies Highlights TPOXX Expansion and Global Health Strategy in New Management Presentation
Stock Track | SIGA Technologies Plunges 8.20% After-Hours on Disappointing Q3 Results and Revenue Decline
Stock Track  ·  11-07
Stock Track | SIGA Technologies Plunges 8.20% After-Hours on Disappointing Q3 Results and Revenue Decline
Stock Track | SIGA Technologies Plunges 8.20% After-Hours on Weak Q3 Results and Revenue Decline
Stock Track  ·  11-07
Stock Track | SIGA Technologies Plunges 8.20% After-Hours on Weak Q3 Results and Revenue Decline
SIGA Technologies Q3 EPS $(0.09) Down From $0.02 YoY, Sales $2.620M Down From $10.010M YoY
Benzinga  ·  11-07
SIGA Technologies Q3 EPS $(0.09) Down From $0.02 YoY, Sales $2.620M Down From $10.010M YoY
SIGA Technologies Reports $90.8 Million in Revenue and $28.7 Million Net Income for First Nine Months of 2025
Reuters  ·  11-07
SIGA Technologies Reports $90.8 Million in Revenue and $28.7 Million Net Income for First Nine Months of 2025
Antiviral therapeutics developer SIGA Q3 revenue plummets on lower TPOXX deliveries
Reuters  ·  11-07
Antiviral therapeutics developer SIGA Q3 revenue plummets on lower TPOXX deliveries
Press Release: SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
Dow Jones  ·  11-07
Press Release: SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025
The Bull Case For SIGA Technologies (SIGA) Could Change Following Projected Surge in Global Monkeypox Treatment Demand
Simply Wall St.  ·  10-30
The Bull Case For SIGA Technologies (SIGA) Could Change Following Projected Surge in Global Monkeypox Treatment Demand
SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results
GlobeNewswire  ·  10-30
SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results
SIGA Technologies (SIGA): Examining Valuation After Monkeypox Market Growth Projections Drive Investor Interest
Simply Wall St.  ·  10-29
SIGA Technologies (SIGA): Examining Valuation After Monkeypox Market Growth Projections Drive Investor Interest
SIGA Technologies Inc. Unveils Management Presentation Highlighting TPOXX's Role in Global Health Security and Infectious Disease Strategy
Reuters  ·  08-06
SIGA Technologies Inc. Unveils Management Presentation Highlighting TPOXX's Role in Global Health Security and Infectious Disease Strategy
Pharma firm SIGA Q2 product revenues rise
Reuters  ·  08-06
Pharma firm SIGA Q2 product revenues rise
SIGA Technologies Q2 EPS $0.49 Up From $0.03 YoY, Sales $79.00M Up From $21.81M YoY
Benzinga  ·  08-06
SIGA Technologies Q2 EPS $0.49 Up From $0.03 YoY, Sales $79.00M Up From $21.81M YoY
SIGA Technologies Q2 EPS USD 0.49
THOMSON REUTERS  ·  08-06
SIGA Technologies Q2 EPS USD 0.49
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025
GlobeNewswire  ·  08-06
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
GlobeNewswire  ·  07-29
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
BRIEF-EMA's CHMP Starts Review Of Tecovirimat SIGA
Reuters  ·  07-25
BRIEF-EMA's CHMP Starts Review Of Tecovirimat SIGA

Introduction

Company Name.
SIGA Technologies Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Issue price:
--